C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
David ZahlerKeren-Lee RozenfeldMaya SteinAssi MilwidskyShlomo BerlinerShmuel BanaiYaron ArbelYacov ShachamPublished in: Journal of nephrology (2019)
CRPv might be an independent and rapidly measurable biomarker for AKI following primary PCI in STEMI patients.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- acute kidney injury
- patients undergoing
- end stage renal disease
- st segment elevation myocardial infarction
- randomized controlled trial
- newly diagnosed
- ejection fraction
- coronary artery disease
- acute myocardial infarction
- cardiac surgery
- acute coronary syndrome
- chronic kidney disease
- prognostic factors
- antiplatelet therapy
- peritoneal dialysis
- minimally invasive
- heart failure
- atrial fibrillation
- blood flow
- patient reported outcomes
- ultrasound guided
- left ventricular
- patient reported